Evidence map›Paper›PMID 33400838›Full record

ArticleJournal of surgical oncology2021

Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.

Alisa N Blumenthaler, Timothy E Newhook, Naruhiko Ikoma, Jeannelyn S Estrella, Mariela Blum Murphy, Prajnan Das, Bruce D Minsky, Jaffer A Ajani, Paul F Mansfield, Brian D Badgwell

Abstract read
In one paragraph

Article in Journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alisa N BlumenthalerDepartments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-8830-8509
Timothy E NewhookDepartments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Naruhiko IkomaDepartments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID http://orcid.org/0000-0002-9825-9234
Jeannelyn S EstrellaDepartments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mariela Blum MurphyDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Prajnan DasDepartments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bruce D MinskyDepartments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jaffer A AjaniDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Paul F MansfieldDepartments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brian D BadgwellDepartments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
TRAINING OF ACADEMIC SURGICAL ONCOLOGISTST32CA009599 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Ashley M Holder, Jennifer A. Wargo · 1988 to 2026
$13.2M
Holly Clegg Gastric Cancer Research Fund No Stomach For Cancer Award for Gastric Cancer ResNCI NIH HHS P30 CA016672NCI NIH HHS T32 CA009599NIH HHS P30 CA016672NIH HHS T32 CA009599
6 · The paper itself

Abstract

BACKGROUND AND

objectivesWe sought to evaluate the impact of lymphovascular invasion (LVI) and perineural invasion (PNI) on survival outcomes in gastric cancer patients treated with preoperative therapy.

methodsPatients with gastric cancer treated with preoperative therapy and potentially curative resection were stratified according to the presence of LVI, PNI, or both. Kaplan-Meier and Cox regression analyses were used to evaluate the impact on overall survival (OS) and disease-free survival (DFS).

resultsThe study included 281 patients, of whom 93 (33%) had LVI, 69 (25%) had PNI, 51 (18%) had both LVI and PNI, and 170 (61%) had neither. LVI and PNI were each associated with higher ypT and ypN categories and more positive lymph nodes (all p < .001), associations that were emphasized with both factors present. On multivariable analyses, ypN (p < .001) and concurrent LVI/PNI (hazard ratio [HR]: 2.62; 95% confidence interval [CI]: 1.55-4.45; p = .001) were predictive of OS and DFS (ypN: p < .001; both LVI/PNI: HR: 2.27; 95% CI: 1.34-3.82; p = .002).

conclusionsGastric cancer patients with concurrent LVI and PNI after preoperative therapy have more advanced disease and worse survival outcomes than patients with neither or only one of these factors.

Indexed as

Preoperative CareAdenocarcinomaChemoradiotherapyFemaleFollow-Up StudiesHumansLymph NodesMaleMiddle AgedNeoadjuvant TherapyNeoplasm InvasivenessPerineumPrognosisProspective StudiesRetrospective StudiesStomach Neoplasmslymphovascular invasionneoplasm invasivenessperineural invasionpreoperative therapystomach neoplasms

Identifiers

PMID33400838
PMCPMC7906958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.